Literature DB >> 11198509

Thalidomide therapy in childhood tuberculous menigitis.

J F Schoeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11198509     DOI： 10.1177/088307380001501221

Source DB:  PubMed          Journal:  J Child Neurol        ISSN： 0883-0738            Impact factor:   1.987


× No keyword cloud information.
  4 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

2.  Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.

Authors:  Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H Freedman; David Stirling; Gilla Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Approach to the Diagnosis and Management of Tuberculous Meningitis.

Authors:  Scott W. Sinner; Allan R. Tunkel
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 4.  Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.

Authors:  Yoo Jin Jung; David Tweedie; Michael T Scerba; Nigel H Greig
Journal:  Front Cell Dev Biol       Date:  2019-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.